|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/443 | |
| A61K 31/47 | |||
| A61K 45/06 | |||
| A61K 9/16 | |||
| A61K 9/20 |
| (11) | Patento numeris | 3068392 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14862504.9 |
| Europos patento paraiškos padavimo data | 2014-10-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-09-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-02-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/063506 |
| Data | 2014-10-31 |
| (87) | Numeris | WO 2015/073231 |
| Data | 2015-05-21 |
| (30) | Numeris | Data | Šalis |
| 201361903010 P | 2013-11-12 | US | |
| 201461929604 P | 2014-01-21 | US | |
| 201462000659 P | 2014-05-20 | US |
| (72) |
SWINNEY, Kelly, Ann, US
HURTER, Patricia, Nell, US
NADIG, David, E., US
SMITH, David, US
THOMAS, Vance, Hayden, US
WARMAN, Martin, Paul, US
|
| (73) |
Vertex Pharmaceuticals Incorporated,
50 Northern Avenue, Boston, MA 02210,
US
|
| (54) | PROCESS OF PREPARING PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CFTR MEDIATED DISEASES |
| PROCESS OF PREPARING PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CFTR MEDIATED DISEASES |